Valuation: Sunflower Pharmaceutical Group Co., Ltd.

Market Cap 6.52B 975M 867M 803M 731M 1.38B 92.53B 1.4B 9.65B 3.79B 48.28B 3.66B 3.58B 154B P/E 2024
24.4x
P/E 2025 -33.6x
Enterprise Value 4.03B 602M 536M 496M 452M 852M 57.18B 866M 5.97B 2.34B 29.84B 2.26B 2.21B 95.12B EV / Sales 2024
2.87x
EV / Sales 2025 2.65x
Free-Float
42.02%
Yield 2024
2.44%
Yield 2025 1.35%
1 day+0.09%
1 week-3.12%
Current month-2.02%
1 month-0.45%
3 months-18.11%
6 months-8.67%
Current year-24.37%
1 week 11.1
Extreme 11.1
11.62
1 month 11.1
Extreme 11.1
11.62
Current year 11.04
Extreme 11.04
15.19
1 year 11.04
Extreme 11.04
15.66
3 years 11.04
Extreme 11.04
30.79
5 years 11.04
Extreme 11.04
31.48
10 years 11.04
Extreme 11.04
31.48
Manager TitleAgeSince
Chief Executive Officer 58 09/02/2026
Director of Finance/CFO 49 06/12/2021
Corporate Officer/Principal 56 20/03/2025
Director TitleAgeSince
Director/Board Member 66 26/03/2014
Director/Board Member 64 26/09/2017
Director/Board Member 44 26/09/2017
Date Insider Type Main position Quantity % Market Cap. Importance
7/17/24 A Buy 500 0.0001%
1/22/20 A Sell

Director

246,300 0.0462%
1/1/20 A Sell 21,300 0.0040%
Change 5-day change 1-year change 3-year change Capi.($)
+0.09%-3.12%-27.33%-54.22% 975M
+0.43%+6.59%+56.57%+106.64% 1,120B
+0.90%-2.25%+32.26%+63.73% 616B
+0.71%+3.24%+24.33%+91.33% 504B
-0.13%+5.98%+33.66%+50.18% 367B
+0.52%+0.24%+72.13%+40.11% 360B
-0.95%+4.70%+19.65%+42.71% 288B
-1.98%+3.73%-0.89%+10.43% 258B
-0.35%+4.25%+44.74%+52.06% 234B
-0.75%+3.32%+27.18%+94.07% 194B
Average -0.15%+2.97%+28.23%+49.70% 394.19B
Weighted average by Cap. +0.13%+3.83%+39.32%+71.79%

Financials

2024 2025
Net sales 3.38B 505M 449M 416M 378M 714M 47.9B 725M 5B 1.96B 25B 1.89B 1.85B 79.68B 2.32B 346M 308M 285M 260M 490M 32.88B 498M 3.43B 1.35B 17.16B 1.3B 1.27B 54.69B
Net income 492M 73.54M 65.37M 60.59M 55.12M 104M 6.98B 106M 728M 286M 3.64B 276M 270M 11.61B -258M -38.53M -34.25M -31.75M -28.88M -54.5M -3.66B -55.38M -382M -150M -1.91B -145M -142M -6.08B
Net Debt -2.29B -342M -304M -282M -256M -484M -32.47B -492M -3.39B -1.33B -16.95B -1.28B -1.26B -54.02B -2.49B -372M -331M -307M -279M -527M -35.35B -535M -3.69B -1.45B -18.45B -1.4B -1.37B -58.8B
Projected Income Statement - Annual - Sunflower Pharmaceutical Group Co., Ltd.
Logo Sunflower Pharmaceutical Group Co., Ltd.
Sunflower Pharmaceutical Group Co Ltd is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company operates its businesses through three segments. The Headquarters Segment is responsible for investment management. The Pharmaceutical segment is mainly responsible for pharmaceutical production and sales. Other segment is mainly responsible for the production of packaging materials and the cultivation and research of Chinese herbal medicines. The Company’s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in the domestic market.
Employees
5,025
Date Price Change Volume
16/10/26 CN¥11.17 +0.09% 4,937,269
15/10/26 CN¥11.16 -2.11% 3,942,800
14/10/26 CN¥11.40 +0.62% 2,915,458
13/10/26 CN¥11.33 -1.39% 3,548,967
12/10/26 CN¥11.49 -0.35% 3,679,900

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Sunflower Pharmaceutical Group Co., Ltd.
  1. Stock Market
  2. Stocks
  3. 002737 Stock